Cyclogyl (Cyclopentolate) Eye Drops

What Is Cyclogyl and What Is It Used For?

Quick Answer: Cyclogyl (cyclopentolate hydrochloride 1%) is an anticholinergic eye drop that dilates the pupil and temporarily paralyzes the eye’s focusing muscles. It is used during eye examinations and to treat certain types of eye inflammation.

Cyclogyl contains the active ingredient cyclopentolate hydrochloride, a potent anticholinergic (antimuscarinic) agent that works by blocking the action of the neurotransmitter acetylcholine at muscarinic receptors in the eye. This produces two key pharmacological effects: mydriasis (dilation of the pupil) and cycloplegia (temporary paralysis of the ciliary muscle responsible for focusing).

In clinical ophthalmology, Cyclogyl is one of the most widely used cycloplegic agents, particularly valued for its relatively rapid onset of action (typically 15–60 minutes) and moderate duration of effect (usually resolving within 24 hours). These properties make it ideal for routine diagnostic procedures where temporary pupil dilation and loss of accommodation are required.

Primary Clinical Uses

Cyclogyl is prescribed for the following clinical indications:

• Diagnostic eye examinations (fundoscopy) — Dilation of the pupil allows ophthalmologists and optometrists to examine the retina, optic nerve, and blood vessels at the back of the eye. This is essential for detecting conditions such as diabetic retinopathy, macular degeneration, and glaucoma.
• Cycloplegic refraction — By temporarily paralyzing the ciliary muscle, cyclopentolate prevents accommodation (the ability of the eye to change focus). This provides a more accurate measurement of refractive error, which is particularly important in children who tend to accommodate during refraction testing.
• Treatment of anterior uveitis and iridocyclitis — In inflammatory conditions of the iris and ciliary body, Cyclogyl helps to reduce pain by relaxing the ciliary muscle spasm and prevents the formation of posterior synechiae (adhesions between the iris and lens).
• Pre-operative and post-operative mydriasis — Cyclogyl may be used before and after certain eye surgeries to maintain pupil dilation and reduce inflammation.

Cyclopentolate hydrochloride is available in different formulations. The standard multi-dose bottle (DROPTAINER) contains 15 mL of solution with benzalkonium chloride as a preservative. Single-dose preservative-free units are also available for patients with sensitive eyes or those who use contact lenses frequently.

Mechanism of Action

Cyclopentolate exerts its effects by competitively blocking acetylcholine at the muscarinic M3 receptors located in the sphincter muscle of the iris and the ciliary body. When acetylcholine is blocked at the iris sphincter, the dilator muscle of the iris (innervated by the sympathetic nervous system) acts unopposed, causing the pupil to dilate. Simultaneously, blocking muscarinic receptors in the ciliary body prevents contraction of the ciliary muscle, which normally facilitates near-focusing (accommodation). The result is a dilated, non-accommodating eye that allows comprehensive examination of internal structures.

Compared to atropine, another anticholinergic used in ophthalmology, cyclopentolate has a faster onset and shorter duration of action. While atropine effects can last 7–14 days, cyclopentolate typically resolves within 24 hours, making it far more practical for routine diagnostic use. However, its cycloplegic effect is generally considered less complete than that of atropine, which remains the gold standard for cycloplegic refraction in young children with significant accommodative capacity.

What Should You Know Before Using Cyclogyl?

Quick Answer: Cyclogyl must not be used in patients with narrow-angle glaucoma or shallow anterior chambers. It should not be used in infants under 1 year old. Special caution is required in children, elderly patients, and those with fever or in hot climates.

Contraindications

You must not use Cyclogyl if any of the following applies to you:

• Allergy to cyclopentolate hydrochloride or any of the other ingredients in the product, including benzalkonium chloride, boric acid, potassium chloride, disodium edetate, sodium carbonate monohydrate, or hydrochloric acid.
• Narrow anterior chamber angle or shallow anterior chamber — Using Cyclogyl in patients with these anatomical features can precipitate an attack of acute angle-closure glaucoma, a medical emergency characterized by a sudden, dangerous increase in intraocular pressure. If you have been told by an eye doctor that you have narrow angles, inform them before any drops are administered.

Warnings and Precautions

Talk to your doctor or pharmacist before using Cyclogyl if any of the following applies to you:

• Risk of elevated intraocular pressure — Even in patients without narrow angles, cyclopentolate can temporarily increase intraocular pressure. Your eye doctor should check your eye pressure before starting treatment, particularly if you have a history of glaucoma or ocular hypertension.
• Behavioral changes — Cyclopentolate can cause central nervous system effects including hallucinations, confusion, agitation, and disorientation. These effects are more common in elderly patients but can occur at any age. Patients should be monitored, especially after the first dose.
• Photosensitivity — Because the pupil is dilated and cannot constrict normally, eyes become highly sensitive to light. Protect your eyes from bright light or sunlight by wearing dark sunglasses until the effects wear off.
• Fever or hot climate — Anticholinergic drugs can impair the body’s ability to regulate temperature through sweating. If you have a fever or are in a warm environment, consult your doctor before using Cyclogyl, as the drug may exacerbate heat-related problems.

Use in Children

When Cyclogyl is used in children over 1 year of age, the following precautions should be observed:

• Always use the lowest effective concentration and the fewest drops necessary to achieve the desired effect.
• Children with Down syndrome, brain injury, or epilepsy are at increased risk of systemic toxicity and should only receive Cyclogyl under close medical supervision.
• Keep children under close observation for at least 30 minutes after administration of the eye drops.
• Do not feed the child for 4 hours after the drops have been given, as feeding intolerance has been reported.
• If any drop misses the eye and lands on the skin, wash it away immediately with water to prevent systemic absorption through the skin.

Pregnancy and Breastfeeding

If you are pregnant, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

• Pregnancy: Cyclogyl should not be used during pregnancy unless your doctor considers it absolutely necessary. There is limited data on the safety of cyclopentolate in pregnant women. The potential risks to the developing fetus should be weighed against the clinical benefit.
• Breastfeeding: Cyclogyl should not be used during breastfeeding. Anticholinergic agents may pass into breast milk and could potentially affect the nursing infant.

Driving and Operating Machinery

Cyclogyl can cause drowsiness, blurred vision, and light sensitivity that may persist for several hours after instillation. You should not drive a car, ride a bicycle, or operate machinery until your vision has fully returned to normal. Plan to have someone drive you home after an eye examination that involves dilation with cyclopentolate.

Contact Lens Wearers

How Does Cyclogyl Interact with Other Drugs?

Quick Answer: Cyclogyl can interact with antihistamines, tricyclic antidepressants, and pilocarpine eye drops. Inform your doctor about all medications you are currently using before Cyclogyl is administered.

Drug interactions with cyclopentolate are primarily related to its anticholinergic mechanism of action. When combined with other medications that also have anticholinergic properties, there is a risk of additive effects that can increase the likelihood of systemic side effects such as dry mouth, rapid heart rate, constipation, urinary retention, and central nervous system disturbances.

Although Cyclogyl is administered topically to the eye, a portion of each drop can be absorbed into the systemic circulation through the nasolacrimal duct and the conjunctival blood vessels. This systemic absorption, though typically small, can be sufficient to produce interactions with other medications, particularly in children and elderly patients who are more susceptible to anticholinergic effects.

Minimizing Drug Interactions

To minimize the risk of drug interactions when using Cyclogyl:

• Tell your doctor or pharmacist about all medicines you are taking, including over-the-counter medications, herbal supplements, and other eye drops.
• If you use other eye drops or ointments, wait at least 5 minutes between each medication. Eye ointments should always be applied last.
• Apply gentle pressure to the inner corner of the eye (nasolacrimal occlusion) for 2 minutes after instilling the drops to reduce systemic absorption and the potential for drug interactions.

What Is the Correct Dosage of Cyclogyl?

Quick Answer: Dosage is individualized by your doctor. For adults, typically 1–2 drops of 1% solution per eye, with repeat dosing as needed. In children over 1 year, the lowest effective dose should always be used. Never use in infants under 1 year.

The dosage of Cyclogyl is determined by your prescribing physician and is tailored to the individual clinical situation. The concentration (1%) and the number of drops are adjusted based on the patient’s age, the purpose of use (diagnostic vs. therapeutic), and the degree of dilation or cycloplegia required. Below are general dosing guidelines based on published clinical recommendations.

How to Apply Cyclogyl Eye Drops Correctly

Proper administration technique is important to maximize the effectiveness of the drops and minimize systemic absorption and side effects. Follow these steps carefully:

1. Wash your hands thoroughly with soap and water.
2. Check the bottle: If the safety collar is loose when the cap is removed, take it off before using the product.
3. Tilt your head back and look upward. With a clean finger, gently pull down your lower eyelid to form a small pocket.
4. Hold the bottle upside down between your thumb and middle finger. Bring the dropper tip close to your eye without touching it.
5. Gently squeeze the bottle to release one drop into the pocket formed by the lower eyelid. The bottle is designed to require only light pressure at the bottom.
6. Close your eye gently and press a finger against the inner corner of your eye (near the nose) for 2 minutes. This nasolacrimal occlusion prevents the medication from draining into the systemic circulation and significantly reduces the risk of systemic side effects.
7. If treating both eyes, repeat steps 3–6 for the other eye.
8. Replace the cap immediately after use to prevent contamination.

Missed Dose

If you forget to use a dose, apply it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not use a double dose to make up for a forgotten one.

Overdose

In the event of ocular overdose (too many drops applied to the eye), flush the eye with warm water. Do not apply any more drops until the next scheduled dose.

Signs and symptoms of systemic overdose from cyclopentolate may include:

• Facial flushing and dry, red skin (children may develop a rash)
• Blurred vision and dilated pupils
• Rapid and irregular heartbeat (tachycardia)
• Fever and dry mucous membranes
• Abdominal distension (particularly in infants)
• Seizures, hallucinations, loss of coordination
• Hyperactivity alternating with drowsiness
• Nausea and vomiting
• In severe cases: low blood pressure, respiratory depression, and respiratory arrest

What Are the Side Effects of Cyclogyl?

Quick Answer: Common side effects include temporary stinging, light sensitivity, and blurred near vision. Systemic effects such as hallucinations, confusion, rapid heartbeat, and facial flushing may also occur. Children and elderly patients are at higher risk of serious side effects.

Like all medicines, Cyclogyl can cause side effects, although not everybody gets them. Side effects from cyclopentolate can be divided into local (eye-related) effects and systemic (whole-body) effects. Systemic effects occur because a portion of the eye drops can be absorbed into the bloodstream through the nasolacrimal duct and conjunctival blood vessels.

The frequency and severity of side effects can vary significantly between individuals. Children, particularly those under 6 years old, premature infants, and patients with central nervous system disorders (such as epilepsy, brain injury, or Down syndrome), are at significantly higher risk of systemic toxicity. Elderly patients are also more susceptible to anticholinergic effects, especially cognitive and cardiovascular effects.

Additional Side Effects in Children

Premature infants, young children, and children with central nervous system disorders (such as epilepsy, brain injury, or Down syndrome) are at increased risk of toxic effects from cyclopentolate. In these vulnerable populations, the drug can cause:

• Central nervous system disturbances: Incoherent speech, restlessness, hallucinations, hyperactivity, disorientation, and seizures
• Cardiovascular effects: Rapid or irregular heartbeat
• Gastrointestinal effects: Abdominal distension, decreased bowel motility, and feeding intolerance
• Respiratory effects: Breathing difficulties
• Necrotizing enterocolitis: A severe, potentially life-threatening intestinal condition reported in premature infants
• Food hypersensitivity: Has been reported following use in children
• Skin rash: Local allergic reactions have been observed

How Should You Store Cyclogyl?

Quick Answer: Store below 25°C (77°F), keep out of reach of children, and discard the bottle 4 weeks after first opening. Do not use after the expiration date.

Proper storage of Cyclogyl is essential to maintain the sterility and effectiveness of the eye drops. Contaminated or degraded eye drops can cause eye infections or reduced therapeutic effect.

• Temperature: Store at or below 25°C (77°F). Do not freeze.
• After opening: Discard the bottle 4 weeks after first opening, even if there is solution remaining. After this period, the preservative may no longer adequately prevent microbial contamination.
• Expiry date: Do not use after the expiration date printed on the packaging (marked “EXP”). The expiry date refers to the last day of the indicated month.
• Keep out of reach: Store this medicine out of the sight and reach of children.
• Disposal: Do not dispose of unused medicines via wastewater or household waste. Return unused or expired medication to your pharmacy for safe disposal to protect the environment.

What Does Cyclogyl Contain?

Quick Answer: The active substance is cyclopentolate hydrochloride (10 mg per mL, i.e., 1% solution). The solution also contains benzalkonium chloride as a preservative, along with buffering and stabilizing agents.

Active Ingredient

Each milliliter of Cyclogyl solution contains 10 mg of cyclopentolate hydrochloride (equivalent to a 1% w/v solution). Cyclopentolate hydrochloride is a white, crystalline powder that is freely soluble in water. It is a synthetic anticholinergic compound structurally related to atropine but with a shorter duration of action.

Inactive Ingredients (Excipients)

• Benzalkonium chloride — Preservative (0.1 mg/mL, approximately 0.003 mg per drop). Can be absorbed by soft contact lenses.
• Boric acid — Buffer to maintain pH stability
• Potassium chloride — Tonicity agent
• Disodium edetate (EDTA) — Chelating agent to enhance preservative effectiveness
• Sodium carbonate monohydrate and/or hydrochloric acid — pH adjustment
• Purified water — Vehicle

Appearance and Packaging

Cyclogyl is a colorless to slightly yellowish solution supplied in a 15 mL plastic bottle (DROPTAINER) with a screw cap. The bottle is designed to deliver consistent drop sizes with light pressure applied at the base. Single-dose preservative-free units containing 1% solution are also available for specific clinical situations.

References

This article is based on the following evidence-based sources and international guidelines:

1. European Medicines Agency (EMA). Summary of Product Characteristics — Cyclopentolate hydrochloride ophthalmic solution. Updated 2024.
2. American Academy of Ophthalmology (AAO). Preferred Practice Pattern: Comprehensive Adult Medical Eye Evaluation. 2024.
3. British National Formulary (BNF). Monograph: Cyclopentolate Hydrochloride. 2025.
4. World Health Organization (WHO). WHO Model List of Essential Medicines — 23rd List. 2023.
5. Manny RE, Hussein M, Scheiman M, et al. “Tropicamide (1%): An effective cycloplegic agent for myopic children.” Investigative Ophthalmology & Visual Science. 2001;42(8):1728–1735.
6. Egashira SM, Kish LL, Twelker JD, et al. “Comparison of cyclopentolate versus tropicamide cycloplegia in children.” Optometry and Vision Science. 1993;70(12):1019–1026.
7. Rengstorff RH, Doughty CB. “Mydriatic and cycloplegic drugs: a review of ocular and systemic complications.” American Journal of Optometry and Physiological Optics. 1982;59(2):162–177.
8. Farkouh A, Frigo P, Geitzenauer W. “Systemic side effects of eye drops: a pharmacokinetic perspective.” Clinical Ophthalmology. 2016;10:2433–2441. doi:10.2147/OPTH.S118409.
9. National Institute for Health and Care Excellence (NICE). Clinical Knowledge Summaries: Mydriatics and cycloplegics. Updated 2024.
10. U.S. Food and Drug Administration (FDA). Cyclopentolate Hydrochloride Ophthalmic Solution — Drug Label Information. DailyMed.

Editorial Team

This article has been written and reviewed by the iMedic Medical Editorial Team, comprising licensed specialist physicians with expertise in ophthalmology and clinical pharmacology.

Disclosure: The iMedic editorial team receives no funding from pharmaceutical companies. All content is independently produced with no commercial influence. Read more about our editorial standards and medical team.